1
Department of toxicology and pharmacology, faculty os medical sciences, Tarbiat Modares University, Tehran, Iran
2
مرکز تحقیقات طب سنتی و مفردات پزشکی و گروه داروسازی سنتی دانشکده طب سنتی ،دانشگاه علوم پزشکی شهید بهشتی
Abstract
Objective: Alzheimer's disease (AD) is the most common form of dementia in the elderly. One of the major pathological hallmarks of AD is extracellular deposition of aggregated beta-amyloid (Aβ) peptide in the brain. Aβ causes neural cell death through several mechanisms. New treatments for AD focus on compounds that can modify disease progression and reduce symptoms through several mechanisms. Medicinal plants include several compounds with heterogeneous pharmacological effects that can be effective in the treatment of AD through different mechanisms. The aim of this study is to evaluate the protective effect of a methanolic extract of seven medicinal plants from Iran on Aβ induced toxicity in a cell culture model. Methods: We cultured PC12 cells according to standard protocols. The cells were incubated with Aβ alone or with different concentrations of extracts for 24 hours. Cell viability was measured using the MTT assay. Results: Sanguisorba minor, Cerasus microcarpa, Ferulago angulate,andRosa caninasignificantly reduced Aβ-induced cell death in the PC12 cell culture. The observed protective effects of extracts were dose-dependent. We did not observe any protective effects with the Stachys pilifera,Amygdalus scoparia, and Alhagi pseudalhagi extracts. Conclusion: Sanguisorba minor, Cerasus microcarpa,Ferulago angulate, andRosa canina extracts could be considered for treatment of AD.
[2]Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007; 3(3): 186-91.
[3]Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 2002; 68(3): 209-45.
[4]Prasansuklab A, Tencomnao T. Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (A β ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy. Evid Based Complement Alternat Med 2013; 2013: 413808.
[5]Barage SH, Sonawane KD. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease. Neuropeptides 2015; 52: 1-18.
[6]Ferreira ME, de Vasconcelos AS, da Costa Vilhena T, da Silva TL, da Silva Barbosa A, Gomes AR, Dolabela MF, Percário S. Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies? Cell Mol Neurobiol 2015; 35(5): 595-614.
[7]Cavallucci V, D'Amelio M, Cecconi F. Aβ toxicity in Alzheimer's disease. Mol Neurobiol 2012; 45(2): 366-78.
[8]Crews L, Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet 2010; 19(R1): R12-20.
[9]Kulshreshtha A, Piplani P. Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease. Neurol Sci 2016; 37(9): 1403-35.
[10]Praticò D, Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 2004; 6(2): 171-5.
[11]Cai Z, Zhao B, Ratka A. Oxidative stress and β-amyloid protein in Alzheimer's disease. Neuromolecular Med 2011; 13(4): 223-50.
[12]Feng Y, Wang X. Antioxidant therapies for Alzheimer's disease. Oxid Med Cell Longev 2012; 2012: 472932.
[13]Contestabile A. The history of the cholinergic hypothesis. Behav Brain Res 2011; 221(2): 334-40.
[14]Deardorff WJ, Feen E, Grossberg GT. The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease. Drugs Aging 2015; 32(7): 537-47.
[15]Howes MJ, Houghton PJ. Ethnobotanical treatment strategies against Alzheimer's disease. Curr Alzheimer Res 2012; 9(1): 67-85.
[16]Howes MJ, Perry E. The role of phytochemicals in the treatment and prevention of dementia. Drugs Aging 2011; 28(6): 439-68.
[17]Perry E, Howes MJ. Medicinal plants and dementia therapy: herbal hopes for brain aging? CNS Neurosci Ther 2011; 17(6): 683-98.
[18]Soodi M, Naghdi N, Hajimehdipoor H, Choopani S, Sahraei E. Memory-improving activity of Melissa officinalis extract in naïve and scopolamine-treated rats. Res Pharm Sci 2014; 9(2): 107-14.
[19]Papandreou MA, Tsachaki M, Efthimiopoulos S, Cordopatis P, Lamari FN, Margarity M. Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection. Behav Brain Res 2011; 219(2): 197-204.
[20]Azali Sahak MK, Mohamed AM, Hashim NH, Hasan Adli DS. Nigella sativa oil enhances the spatial working memory performance of rats on a radial arm maze. Evidence-Based Complementary and Alternative Medicine. 2013 (2013), Article ID 180598, 5 pages.
[21]Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi A, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry 2003; 74(7): 863-6.
[22]Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SSh, Yousefi MH, Alimardani R, Jamshidi A, Zare F, Moradi A. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial. J Clin Pharm Ther 2010; 35(5): 581-8.
[23]Hajimehdipoor H, Shekarchi M, Aghighi A, Hamzeloo-Moghadam M. Evaluating the acetylcholinesterase inhibitory activity of Ferulago angulata and Ferulago subvelutina. RJP 2014; 1(2): 39-43
[24]Esmaeili S, Ara L, Hajimehdipoor H, Kolivand H, Mohammadi Motamed S. Acetylcholinesterase inhibitory effects of some plants from Rosaceae. RJP 2015; 2(4): 33-7.
[25]Ferreira A, Proença C, Serralheiro ML, Araújo ME. The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. J Ethnopharmacol 2006; 108(1): 31-7.
[26]Karkanis A, Vellios E, Thomaidis T, Bilalis D, Efthimiadou A, Travlos I. Phytochemistry and Biological Properties of Burnet Weed (Sanguisorba spp.): A Review. Not Sci Biol 2014; 6(4): 395-8.
[27]Anand P, Singh B. Flavonoids as lead compounds modulating the enzyme targets in Alzheimer’s disease. Med Chem Res 2013; 22(7): 3061-75.
[29]Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Farbood Y, Sarkaki A, Bavarsad K. Gallic acid prevents memory deficits and oxidative stress induced by intracerebroventricular injection of streptozotocin in rats. Pharmacol Biochem Behav 2013; 111: 90-6.
[30]Dhingra D, Chhillar R. Antidepressant-like activity of ellagic acid in unstressed and acute immobilization-induced stressed mice. Pharmacol Rep 2012; 64(4): 796-807.
[31]Ansari MA, Abdul HM, Joshi G, Opii WO, Butterfield DA. Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease. J Nutr Biochem 2009; 20(4): 269-75.
[32]Jiménez B, Grande MC, Anaya J, Torres P, Grande M. Coumarins from Ferulago capillaris and F. brachyloba. Phytochemistry 2000; 53(8): 1025-31.
[33]Cai Z. Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review). Mol Med Rep 2014; 9(5): 1533-41.
[34]Daneshmand P, Saliminejad K, Dehghan Shasaltaneh M, Kamali K, Riazi GH, Nazari R, Azimzadeh P, Khorram Khorshid HR. Neuroprotective Effects of Herbal Extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on Rat Model of Sporadic Alzheimer's Disease. Avicenna J Med Biotechnol 2016; 8(3): 120-5.
[35]Ebrahimi A, Schluesener H. Natural polyphenols against neurodegenerative disorders: potentials and pitfalls. Ageing Res Rev 2012; 11(2): 329-45.
[36]Inestrosa NC, Urra S, Colombres M. Acetylcholinesterase (AChE)--amyloid-beta-peptide complexes in Alzheimer's disease. the Wnt signaling pathway. Curr Alzheimer Res 2004; 1(4): 249-54.
[37]Svensson AL, Nordberg A. Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells. Neuroreport 1998; 9(7): 1519-22.
[38]Anekonda TS, Reddy PH. Can herbs provide a new generation of drugs for treating Alzheimer's disease? Brain Res Brain Res Rev 2005; 50(2): 361-76.
Soodi,M. , Hajimehdipoor,H. , Ataei,N. and Akbari,S. (2016). Study of the Protective Effects of Seven Iranian Medicinal Plant Extracts against Beta-Amyloid Induced Cytotoxicity in PC12 Cells. Pathobiology Reserach, 19(3), 45-58.
MLA
Soodi,M. , Hajimehdipoor,H. , Ataei,N. , and Akbari,S. . "Study of the Protective Effects of Seven Iranian Medicinal Plant Extracts against Beta-Amyloid Induced Cytotoxicity in PC12 Cells", Pathobiology Reserach, 19, 3, 2016, 45-58.
HARVARD
Soodi,M.,Hajimehdipoor,H.,Ataei,N.,Akbari,S. (2016). 'Study of the Protective Effects of Seven Iranian Medicinal Plant Extracts against Beta-Amyloid Induced Cytotoxicity in PC12 Cells', Pathobiology Reserach, 19(3), pp. 45-58.
CHICAGO
M. Soodi, H. Hajimehdipoor, N. Ataei and S. Akbari, "Study of the Protective Effects of Seven Iranian Medicinal Plant Extracts against Beta-Amyloid Induced Cytotoxicity in PC12 Cells," Pathobiology Reserach, 19 3 (2016): 45-58,
VANCOUVER
Soodi,M.,Hajimehdipoor,H.,Ataei,N.,Akbari,S. Study of the Protective Effects of Seven Iranian Medicinal Plant Extracts against Beta-Amyloid Induced Cytotoxicity in PC12 Cells. Pathobiology Reserach, 2016; 19(3): 45-58.
Pathobiology Reserach